Press Releases Items Per Page 102550 Year None2021202020192018 02-24-2021 Akero Therapeutics Initiates Phase 2b HARMONY Study of Efruxifermin (EFX) for the Treatment of NASH 02-23-2021 Akero Therapeutics to Participate in Upcoming Virtual Healthcare Conferences in March 01-04-2021 Akero Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
02-24-2021 Akero Therapeutics Initiates Phase 2b HARMONY Study of Efruxifermin (EFX) for the Treatment of NASH
